1. Home
  2. DOMO vs CADL Comparison

DOMO vs CADL Comparison

Compare DOMO & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$3.91

Market Cap

132.7M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.68

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
CADL
Founded
2010
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.7M
1.0B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
DOMO
CADL
Price
$3.91
$10.68
Analyst Decision
Buy
Strong Buy
Analyst Count
9
7
Target Price
$10.28
$19.00
AVG Volume (30 Days)
1.1M
1.3M
Earning Date
05-20-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
58.62
EPS
N/A
N/A
Revenue
$318,857,000.00
$125,000.00
Revenue This Year
$3.41
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.84
$4.35
52 Week High
$18.49
$14.00

Technical Indicators

Market Signals
Indicator
DOMO
CADL
Relative Strength Index (RSI) 54.45 35.42
Support Level $3.62 $9.18
Resistance Level $4.05 $10.59
Average True Range (ATR) 0.15 0.70
MACD -0.01 -0.41
Stochastic Oscillator 59.26 11.22

Price Performance

Historical Comparison
DOMO
CADL

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: